CervoMed Inc (CRVO)
24.24
+0.15
(+0.62%)
USD |
NASDAQ |
May 20, 09:59
CervoMed Total Liabilities (Quarterly): 2.661M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 2.661M |
December 31, 2023 | 2.596M |
September 30, 2023 | 2.464M |
June 30, 2023 | 1.465M |
March 31, 2023 | 2.126M |
December 31, 2022 | 37.44M |
September 30, 2022 | 2.271M |
June 30, 2022 | 2.515M |
March 31, 2022 | 2.956M |
December 31, 2021 | 2.928M |
September 30, 2021 | 2.749M |
June 30, 2021 | 2.544M |
March 31, 2021 | 2.566M |
December 31, 2020 | 2.915M |
September 30, 2020 | 3.193M |
June 30, 2020 | 3.116M |
March 31, 2020 | 3.156M |
December 31, 2019 | 3.976M |
September 30, 2019 | 2.678M |
June 30, 2019 | 2.752M |
March 31, 2019 | 3.033M |
December 31, 2018 | 2.590M |
September 30, 2018 | 2.687M |
June 30, 2018 | 2.644M |
March 31, 2018 | 3.646M |
Date | Value |
---|---|
December 31, 2017 | 4.916M |
September 30, 2017 | 21.97M |
June 30, 2017 | 32.74M |
March 31, 2017 | 55.46M |
December 31, 2016 | 8.300M |
September 30, 2016 | 7.561M |
June 30, 2016 | 5.892M |
March 31, 2016 | 6.332M |
December 31, 2015 | 2.318M |
September 30, 2015 | 4.309M |
June 30, 2015 | 4.842M |
March 31, 2015 | 4.368M |
December 31, 2014 | 4.613M |
September 30, 2014 | 7.748M |
June 30, 2014 | 9.232M |
March 31, 2014 | 14.23M |
December 31, 2013 | 11.88M |
September 30, 2013 | 9.571M |
June 30, 2013 | 8.767M |
March 31, 2013 | 21.92M |
December 31, 2012 | 20.85M |
September 30, 2012 | 9.981M |
June 30, 2012 | 8.777M |
March 31, 2012 | 5.768M |
December 31, 2011 | 19.68M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.465M
Minimum
Jun 2023
37.44M
Maximum
Dec 2022
4.453M
Average
2.714M
Median
Total Liabilities (Quarterly) Benchmarks
GlucoTrack Inc | 1.708M |
AIM ImmunoTech Inc | 9.147M |
Perspective Therapeutics Inc | 48.40M |
Protalix BioTherapeutics Inc | 60.04M |
Armata Pharmaceuticals Inc | 176.87M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 7.997M |
Shareholders Equity (Quarterly) | 5.336M |